» Articles » PMID: 36091254

An Anti-inflammatory and Low Fermentable Oligo, Di, and Monosaccharides and Polyols Diet Improved Patient Reported Outcomes in Fibromyalgia: A Randomized Controlled Trial

Overview
Journal Front Nutr
Date 2022 Sep 12
PMID 36091254
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fibromyalgia (FM) has been associated with dysbiosis and low-grade inflammation. Studies have reported that diet influences clinical features in FM.

Objective: To evaluate the effect of an anti-inflammatory and low fermentable oligo, di, and monosaccharides and polyols (FODMAP) diet on clinical outcomes of patients with FM.

Methods: This two arms Randomized Controlled Trial (NCT04007705) included 46 female patients with FM. The intervention group ( = 22) adopted an anti-inflammatory diet for 3 months, excluding gluten, dairy, added sugar, and ultra-processed foods, along with a low FODMAPs diet in the first month. The control group ( = 24) followed general healthy eating recommendations. Both diets were applied by a certified dietitian. Before and after the intervention, participants were assessed regarding pain, fatigue, gastrointestinal symptoms, quality of sleep, and quality of life, through the Revised Fibromyalgia Impact Questionnaire (FIQR), Visual Analogue Pain Scale (VAS), Visual Analog Scale from gastrointestinal symptoms (VAS GI), Brief Pain Inventory (BPI), Pittsburg Sleep Quality Index (PSQI), Fatigue Severity Survey (FSS), and The Short Form Health Survey (SF-36). A blood sample was collected and high-sensitive C-Reactive Protein and Erythrocyte Sedimentation Rate were quantified. Paired Samples -test/Wilcoxon and independent samples -test/Mann-Whitney were used to compare variables between groups.

Results: After intervention, there was an improvement in intervention group scores of FIQR ( = 0.001), VAS ( = 0.002), BPI ( = 0.011), FSS ( = 0.042), VAS_GI ( = 0.002), PSQI ( = 0.048), and SF36 ( = 0.045) compared to control group. Inflammatory biomarkers (hs-CRP, ESR) did not change in both groups. The intervention was beneficial in the intervention group, regardless of age, disease duration, body mass index variation, and body fat change between baseline and post-intervention.

Conclusion: An anti-inflammatory and low-FODMAP diet improved clinical features in patients with FM and may be useful as a complement to pharmacological therapy.

Clinical Trial Registration: [https://clinicaltrials.gov/ct2/show/NCT04007705], identifier [NCT04007705].

Citing Articles

Effectiveness of the SYNCHRONIZE + Brief Intervention in Improving Mediterranean Diet Adherence, Nutritional Quality and Intake Pattern in Persons with Fibromyalgia and Chronic Fatigue Syndrome.

Carrasco-Querol N, Cabricano-Canga L, Bueno Hernandez N, Martin-Borras C, Goncalves A, Vila-Marti A Nutrients. 2025; 17(1.

PMID: 39796445 PMC: 11723387. DOI: 10.3390/nu17010011.


Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes.

Lambiase C, Rossi A, Morganti R, Cancelli L, Grosso A, Tedeschi R Nutrients. 2024; 16(19).

PMID: 39408383 PMC: 11478509. DOI: 10.3390/nu16193419.


Restrictive Diets in Patients with Fibromyalgia: State of the Art.

Almirall M, Muste M, Serrat M, Tourino R, Espartal E, Marsal S Biomedicines. 2024; 12(3).

PMID: 38540241 PMC: 10968491. DOI: 10.3390/biomedicines12030629.


T Lymphocyte Interferon-gamma Response to Anaplasmataceae-related Major Surface Proteins and Ankyrin A in Fibromyalgia.

Puri B, Preyer R, Lee G, Schwarzbach A CNS Neurol Disord Drug Targets. 2024; 23(11):1392-1399.

PMID: 38375844 DOI: 10.2174/0118715273274091231207101522.


Nutrition and Chronobiology as Key Components of Multidisciplinary Therapeutic Interventions for Fibromyalgia and Associated Chronic Fatigue Syndrome: A Narrative and Critical Review.

Carrasco-Querol N, Cabricano-Canga L, Bueno Hernandez N, Goncalves A, Caballol Angelats R, Pozo Ariza M Nutrients. 2024; 16(2).

PMID: 38257075 PMC: 10818822. DOI: 10.3390/nu16020182.


References
1.
Feinberg T, Sambamoorthi U, Lilly C, Innes K . Potential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey. BMC Musculoskelet Disord. 2017; 18(1):294. PMC: 5501008. DOI: 10.1186/s12891-017-1641-y. View

2.
Hawrelak J, Myers S . The causes of intestinal dysbiosis: a review. Altern Med Rev. 2004; 9(2):180-97. View

3.
. Reference method for the erythrocyte sedimentation rate (ESR) test on human blood. Br J Haematol. 1973; 24(5):671-3. DOI: 10.1111/j.1365-2141.1973.tb01693.x. View

4.
Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R . Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010; 110(6):911-16.e12. PMC: 3704564. DOI: 10.1016/j.jada.2010.03.018. View

5.
Costa C, Pinto A, Pereira A, Marques M, Macedo A, Pereira da Silva J . Psychometric properties of the Revised Fibromyalgia Impact Questionnaire (FIQR) - a contribution to the Portuguese validation of the scale. Acta Reumatol Port. 2016; 41(3):240-250. View